Aquila Bioscience has a team of experts from a range of science diciplines, bridging Glycobiology, Immunology, Microbiology, Biochemistry and Analytical Chemistry, providing the highest quality of services and products to its customers.
Research interests lie in the fight against chronic and infectious diseases.

Disease Prevention:

AquilaBio is a pioneer in bringing two critical areas of expertise to the fight against chronic and infectious diseases, cell stress and glycoscience. Aquila Bioscience has a strong focus on the use of polysaccharides for both preventing and treatment of disease. The combined expertise of cell biology and glycobiology at Aquila Bioscience allows our team to investigate the effects of different polysaccharides on a range of disease models.

  Some major areas of interest at Aquila are below:

  • Infectious diseases
    • Viral infections
    • Bacterial infections
  • Auto-immune diseases
    • Inflammatory Bowel Disease / Crohn's disease
    • Rheumatoid Arthritis / Osteoarthritis / Psoriasis
  • Immunodeficiency/Malnutrition
  • Obesity/Diabetes


AquilaBio News

-Jan 05th 2015: Aquila Bioscience sign contract with the European Defense Agency

-Nov 18th 2014: The Natural Product Biotechnology conference

- Oct 13th 2014: Aquila Bioscience meet with NAPES

-Sep 23rd 2014: Aquila Bioscience has been shortlisted in three categories